Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Recent News

03.26 2019
Translate Bio Granted U.S. Patent Relating to Messenger RNA (mRNA) Delivery
03.25 2019
Translate Bio to Participate in Upcoming Investor Conferences
03.21 2019
Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights
03.18 2019
Translate Bio Announces Publication of Preclinical Data Demonstrating Efficacy of Systemic mRNA Delivery in Fabry Disease Model in the Journal Molecular Therapy

View All

@TranslateBio